Recombinant, normal human medium-chain acyl-CoA dehydrogenase (MCADH) and the common, human disease-causing K304E mutant ([Glu304]MCADH) protein were expressed in Escherichia coli using an optimized system, and the enzymes were purified to apparent homogeneity. The crucial factor leading to the production of active [Glu304]MCADH protein is the expression in E. coli cells at reduced temperature (28OC). Expression in the same system at 37°C results in very low amounts of active mutant protein. Several catalytic and physicochemical parameters of these two proteins have been determined and were compared to those of purified pig kidney MCADH. Although [Glu304]MCADH has approximately the same rate of substrate reduction with dodecanoyl-CoA and the same V,,, as human MCADH with the best substrate for the latter, octanoyl-CoA, the K,, in the mutant MCADH is fourfold higher, which generates a correspondingly lower catalytic efficiency. Importantly, V,,, obtained using the natural acceptor, electron transfer flavoprotein, is only a third that for human MCADH. The V,,,/K,,, versus chain-length profile of the mutant shows a maximum with dodecanoyl-CoA which differs markedly from that of human MCADH, which has maximal efficiency with octanoyl-CoA. The substrate specificity of the mutant is broader with a less pronounced activity peak resembling long-chain acyl-CoA dehydrogenase. The purified mutant enzyme exhibits a reduced thermal stability compared to human wild-type MCADH. The major difference between the two proteins expressed in E. coli is the more pronounced lability of the K304E mutant in crude extracts, which suggests a higher susceptibility to attack by endogenous proteases. Differences between tetrameric [Glu304]MCADH which survives the first step(s) of purification and corresponding MCADH are minor. The overall differences in properties of [Glu304]MCADH together with its impaired folding and tetramer assembly may contribute to the generation of the abnormalities observed in patients homozygous for the K304E mutation.
sional structure [ 111. MCADH has special relevance because MCADH deficiency is the most frequently observed genetic defect in mitochondrial fatty acid a-oxidation [12, 131 . About 70-90% of the alleles causing MCADH deficiency carry the A985-G point mutation in their cDNA, which results in the substitution of Lys with Glu at position 304 of the mature enzyme [14-181. The homozygote frequency of the G985 mutation in Caucasians in north-westem Europe and the USA is in the range of 1 in 10000 to 1 in 40000 [18-201. [Glu304]-MCADH is present in patient cells at concentrations dramatically lower than those of native MCADH [14, [21] [22] [23] [24] . Expression studies of [Glu304]MCADH cDNA in both prokaryotic and eucaryotic systems revealed that the mutant variant is capable of forming active enzyme [24- 271 with a specific activity in the range of the wild-type enzyme [26, 271. The major reason for the decreased level of mutant enzyme observed in patient tissues has been attributed to impaired folding and tetramer assembly that presumably results in premature degradation of accumulating deviant folding/assembly intermediates [26, 28 - 
301.
The mutation site in [Glu304]MCADH is located in helix H, at the interface between the subunits of the homotetramer and is [ll] . Recently, we created specific mutations in the vicinity of position K304 to distinguish between the mutational effects on folding and subunit assembly. Expression studies with these variants support the concept of both impaired folding and tetramer assembly as the pathogenic mechanism [30] . These experiments suggested also that the assembled mutant enzyme displays decreased thermostability. The relevance of the decreased thermostability was not clear because detailed studies of the enzymatic and biochemical properties of [Glu304]MCADH in a well-defined system had not been done due to the decreased stability and consequent failure to isolate of [Glu304]MCADH mutant enzyme for these analyses. Furthermore, subsequent to our first report on the expression and isolation of MCADH [6, 171 evidence has been forthcoming that the human MCADH, although overall very similar to its well studied pig counterpart, also exhibits specific differences [7, 311. To overcome these limitations of previous studies, we improved the prokaryotic expression system reported originally [6] and optimized the purification procedure to isolate significant amounts of pure [Glu304]MCADH for biochemical studies. These improvements resulted in an approximately 12-fold higher yield of MCADH and of stable mutants [32] compared to a system recently published by Peterson et al. [7] and in quantities of K304E mutant which did permit its biochemical characterisation. Herein, we report some specific biochemical properties of MCADH allowing direct comparison with the mutant enzyme. These properties are complementary to those described recently by Peterson et al. [7] who focused primarily on kinetic experiments and on the reaction with octanoyl-CoA. The comparison of [Glu304]MCADH with MCADH allows a more detailed evaluation of the contribution of the various effects of the K304E mutation to the impairment of P-oxidation observed in patients.
MATERIALS AND METHODS
Instrumentation. Visible and ultraviolet spectra were recorded with a Kontron Uvikon 930 spectrophotometer, and fluorescence spectra were obtained with a Kontron SFM 25 instrument. Single-turnover experiments were performed with a stopped-flow spectrophotometer which has a 2.0-cm path-length cell [33, 341 and which is equipped with a diode array detector (Spectroscopy Instruments GmbH) and interfaced with a MacIntosh IIcx computer for data acquisition (POSMA 2.3 k software, SI). Rapid reactions were routinely recorded in the range 300-650 nm using the normal scan mode with a scan time of 10 ms/ spectrum and with a resolution of 2 pixeldnm. For reactions proceeding with a kobc > 90 s-', a fast access routine was used, which has an acquisition time of 0.7 ms/data point at 450 nm. For these experiments, the BG24A filter was removed to yield sufficient light intensity. For the determination of kinetic constants, the arithmetic mean of at least three traces was formed, and the resultant was fitted using the A program (Dr D. P. Ballou, University of Michigan, Ann Arbor). Other fit routines were done with KaleidaGraph for MacIntosh from Synergy Software. Unless otherwise stated, all measurements were made at 25°C in 50 mM KP, at pH 7.8. The concentrations mentioned in the context of stopped-flow experiments are those of the reagents after mixing, i.e. 1 : 1 dilution, from the initially prepared solutions.
Materials and enzymes. CoA derivatives, ampicillin, protocatechuate, phenazine methosulfate (PMS) and 2,6-dichloroindophenol (C1,Ind) were from Sigma. Tryptone, yeast-extract, isopropyl P-D-thiogalactopyranoside, Tricine, acrylamidehsacrylamide and Tris from Roth. Sephadex G-25@, Q-Sepharose FFm and SuperdexO pg 200 (XK 26/60) were from Pharmacia. Hydroxyapatite fast flow gel was from Fluka. CoA-persulfide was prepared as described by Williamson et al. [35] . Ferricenium hexafluorophosphate was prepared according to Lehman et al. [36] . 3-Methyl lumiflavin and lumiflavin 3-acetate were made according to Hemmerich [37] . Unless otherwise stated, all buffers contained 0.3 mM EDTA. Additionally, all buffers employed during the MCADH purification contained 1 pM FAD at pH 7.8. ETF from pig kidney was purified according to Gorelick et al. [38] with the exception of the use of Q-Sepharose instead of DEAE-cellulose (DE-52). Although ETF does not adsorb to the DE-52 column, it binds weakly to Q-Sepharose (column, 50x450 mm) from which it can be eluted with a NaCl gradient (0-400 mM NaCl in 450 min with a flow of 4.5 rnll min). Pig kidney MCADH was purified as described by Thorpe et al. [4] , but using Q-Sepharose and hydroxyapatite and an additional octyl-Sepharose step [39] . Protocatechuate dioxygenase was a kind gift from Dr D. P. Ballou (University of Michigan, Ann Arbor).
Absorption coefficients. Absorption coefficients (see Table 2 ) were determined with the SDS and trichloroacetic acid methods [40] . FAD: E~~~ = 11.3 mM-'cm-' [41] ; butyryl-, hexanoyl-, octanoyl-and palmitoyl-CoA: E,,, = 15.4 mM-' cm-' [42] .
Enzyme assays. The following assays were used (see Table 3 ): (a) ETF under anaerobic conditions [43] , but using 6 pM ETF; (b) PMS (1.4 mM)/CI,Ind (35 pM) 141 in 0.7 rnl 100 mM KP, pH 7.6; (c) ETF (10.5 pM)/Cl,Ind [38]; (d) ferrcenium in 50 mM KP, pH 7.6, but without N-ethylmaleimide [36] . Unless otherwise stated, all assays were carried out at 25 "C.
Thermal effects and stability. The Arrhenius activation energy was estimated in the range 5-62°C and in 1 O O m M KP, pH7.6, by addition of equal amounts of MCADH or [Glu304]MCADH to buffer at the correct temperature containing a saturating concentration of octanoyl-CoA (50 pM). Thermal stability was studied by diluting enzyme into such buffer solutions, which were kept at the indicated temperature for 15 min before the assay. For the study of time versus temperature effects on activity (Fig. 6, below) , extracts of Escherichia coli cells were incubated at various temperatures, and aliquots were assayed at incremental times using the ferricenium assay.
Plasmids and expression of human wild-type and [Glu304]MCADH. E. coli cells (strain TG1) were transformed with human wild-type and [Glu304]MCADH-encoding plasmids pTrc MCADH [32] and pTrc [Glu304]MCADH in which the EcoRI-Hind111 fragment coding for the C-terminal MCADH was replaced by the EcoRI-BamHI fragment of p985 [26] carrying the K304E mutation, first subcloned into EcoRUBamHIdigested pUC 8.2 which supplied the needed Hind111 site. Cells were grown in 40 1 (Bioengineering fermentor) dYT medium (16 gil tryptone, 10 g/l yeast extract and 5 g/l NaCl). The expression was performed under conditions as described by Nandy et al. [32] at a growth temperature of 28°C and the cells harvested with a Cepa continuous centrifuge. The wet cell paste (250-300 g) was stored at -20°C.
General procedure for the purification of recombinant MCADHs from E. coli cells. E. coli cell paste (wet, about 120 g) was thawed and suspended in 0.25 M Tris/HCl pH 7.8.
The cell suspension was sonicated three times for 5 rnin (50% pulsed), and the resulting slurry (about 1 1) was centrifuged for 30 min at 15 000 g. The pooled supernatants were fractionated between 40-80 % ammonium sulfate, and the pellet obtained after centrifugation for 30 min at 15000 g was dissolved, dialyzed against 50 mM Tris/HCI, and then loaded on a Q-Sepharose (fast flow) column (30x400 mm, equilibrated with 50 mM 35 [21] TrislHCl, flow rate 4 mllmin). MCADH binds as a greenlyellow band at the top. After elution of unbound protein, a gradient (0-300 and 300-600 mM NaCl in 300 min and 60 min, respectively) was applied, which leads to elution of a green/yellow band at 150 mM NaCl containing the MCADH activity. The color and ionic strength of elution are conveniently used to locate MCADH protein in the case of inactive mutants. The pooled fractions having activity were concentrated by precipitation with 80% ammonium sulfate, and the dissolved pellet was dialyzed against 5 mM KP, pH 7.8. At this point, the protein solution had an A272,444 ratio of 30 and was applied to a hydroxyapatite column (30x220 mm, equilibrated with 5 mM KP, and flow rate of 1.5 mllmin) which was washed extensively with 100 mM KP,.
MCADH was eluted at 300 mM KP, using a linear gradient of 100-500 mM KP, over 300 min. Elution of MCADH usually occurs in two, poorly resolved bands corresponding to the green and yellow forms, respectively, of MCADH. At this stage, the yellow form of MCADH has an A272,444 ratio of about 6 and purity of >90%. Final purification was by gel filtration on a HiLoad 26/60 Superdex 200-pg in 100 mM KP, from which MCADH elutes with an apparent molecular mass of 155 kDa. The isolated MCADH shows a single band on SDSlPAGE with an apparent molecular mass of 42 kDa. It should be noted that a mixture of green and yellow forms of MCADH were usually obtained during purification and that the relative concentration of the two depends on the type of mutant being purified and on the conditions of cell growth and disruption. MCADH preparations were degreened by an adaptation of the method of Williamson et al. [ 3 5 ] : to about 1 ml of a concentrated solution of MCADH (> 100 pM protein), 200 pl of a saturated solution of dithionite in 50 mM KP,, pH 7.8, was added, causing loss of color of the solution. After 2 min, the enzyme was separated from small molecules by filtration over a Sephadex G-25 column (5 ml, equilibrated with 50 mM KP,, pH 7.8). The enzyme reoxidizes during elution and elutes in the yellow form. Addition of CoA-persulfide leads to the green enzyme form.
Miscellaneous methods.
Static spectral experiments were performed at 25°C in 50 mM KP,, pH 7.8, containing 0.3 mM EDTA, when not otherwise indicated. Anaerobiosis was achieved by flushing and evacuation cycles using 0,-free argon in the presence of an oxygen scavenging system (glucose oxidaselglucoselcatalase or protocatechuate dioxygenaselprotocatechuate) either directly in the solution or in a sidearm of the cuvette. Protein was determined with the Pierce Coomassie dyebinding reagent (Bradford assay) according to the manufacturer's instructions.
RESULTS
Expression of human recombinant wild-type MCADH and of [Glu304]MCADH. With our previously described E. coli expression system, yields of about 0.9 mg pure MCADHA cell culture were obtained [6] . Peterson et al. [7] improved this system by using a pETlla-MCAD, E. coli BL21 (DE3)pLysS and reported a yield of about 150 mg pure MCADH from 80-1 fermentor cultures. We had previously explored the same system and obtained comparable results for MCADH and stable mutants. In our hands, however, that expression system was inadequate for a workable purification of the relatively unstable [Glu304]-MCADH. Evaluation of various expression vectors and conditions revealed that our best results were obtained with the expression of MCADH under the control of the strong Trc promoter of the expression vector pTrc99C at growth temperatures of 28°C 1321. This minimizes the problem of aggregation of the recombinant protein and the formation of inclusion bodies. The yield of purified MCADH and of most stable mutants was up to 900 mg from 40-1 fermentor runs, with 5-10% of soluble protein as MCADH in the crude extracts, providing about 25-fold improvement compared to our original system [6] and 12-fold greater yield than Peterson et al. [7] . Expression at low culture temperature was the only method allowing us to obtain soluble, active proteins with some of the labile mutants, particularly
[Glu304]MCADH. Growth temperatures < 28" have no further beneficial effect on the yield. The point should be stressed that for [Glu304]MCADH, and at 37"C, essentially no activity in crude extracts could be detected.
Purification of human recombinant MCADH proteins.
The procedure used for the purification of MCADH and of most mutants is derived from the original one by Thorpe et al. [4] which could be simplified extensively because of the high content of MCADH in crude E. coli extracts. Thus, two chromatographic steps allow the purification of up to 300 mg for some MCADH mutants from about 120 g bacterial paste with an apparent purity > 95 % ( Table 1 ). The major improvement was achieved by the use of Q-Sepharose instead of other anionic-exchange resins and of commercially available hydroxyapatite (Fluka) in an FPLC system. For analytical purposes, a final Pharmacia HIload 26/60 Superdex 200 pg step yields enzyme with an apparent >98% purity. Following expression in E. coli cells, the different MCADH proteins occur as mixtures of their yellow and green forms which correspond to free MCADH and enzyme complexed with CoA-persulfide, respectively 13.5, 441. Physical properties. The visible and ultraviolet absorption spectrum of human MCADH is very similar, but not identical, to those of MCADHs from other sources (Fig. 1 , The reaction with substrates. The effects induced by addition of substrates of varying chain lengths on the spectrum of oxidized MCADH are shown in Fig. 1A . With one equivalent of C,-CoA, about 90% of the spectral changes at 444 nm are observed which are maximally attainable at saturation (not shown).
With the [Glu304]MCADH mutant, five equivalents C,-CoA lead to about 80% reduction. The charge transfer band of reduced MCADH complexed with product species is significantly more intense ( E~,~ = 3.2 mM-' cm-') compared to that of pig kidney MCADH ( E~~~ = 2.5 mM-' cm-') [4] . The same holds for the bands observed with C,-CoA and C,,-CoA, implying a substantially higher thermodynamic stabilization of the reduced enzyme product complex with MCADH than with pig kidney MCADH. In line with this, bleaching at 444 nm is more extensive with MCADH at the same molar excess of C,-CoA (85% versus 79%) [l, 3, 41. The same trend is observed with excess C,-CoA and C,,-CoA; on the other hand, upon addition of one equivalent of C,-CoA to MCADH, reduction is only 11 % compared to 31% with pig kidney MCADH [4] probably reflecting weaker binding (Eox + S t) E,, -S) with the human enzyme. Table 2 .
Catalytic properties and substrate specificity. The catalytic parameters of MCADH and [Glu304]MCADH under turnover conditions and using four different assayslacceptors systems are reported in Table 3 , where the data for the pig enzyme are also listed for comparison. Substrate chain length The data were obtained using the ferrcenium assay [36] as described in Materials and Methods. See Table 3 for the values of V,,, and K,,.
ences, the mutant having long-chain character. In view of the known problems inherent in the measurements of acyl-CoA dehydrogenase activities [48] , the data listed in Table 3 and shown in Fig. 2 were obtained in parallel measurements whenever possible. We have also used the ETF fluorescence assay (ETF purified from pig kidney [43] ) for the comparison of human wildtype and [Glu304]MCADH because this assay most probably best reflects the in vivo conditions. This system displays Michaelis-Menten behavior (Fig. 3) , and it is apparent that [Glu304]-MCADH has about 40% the activity of MCADH, although the interaction constant with ETF is comparable. Pig kidney MCADH has about 50% the activity of MCADH in the same assay (not shown). Preliminary measurements using human recombinant ETF indicate analogous values suggesting that human and pig ETF are similarly efficient in their electron acceptor capacities towards MCADH. Using the ferricenium assay, we found virtually the same V,,, for human wild-type and [Glu304]MCADH with C,-CoA to C,,-CoA. Notable differences for the mutant were found only with C,-CoA and with C,,-CoA which show slightly lower and significantly higher activities respectively (see Table 3 ). Comparison of the data listed in Table 3 indicates that the ferricenium assay [36] is adequate for assessing the catalytic properties of various MCADHs and their chainlength dependence of the activity. This contrasts with the C1,Indbased assays which appear to underestimate the maximally attainable rates in a way not linearly dependent on the substrate chain length ( c -e.g. values for C,-C,-CoA, Table 3 ). For this reason the catalytic properties of [Glu304]MCADH were studied using primarily the ferricenium assay, the large quantities of purified ETF required for the direct fluorescence assay precluding its routine use. Qualitatively, our results for MCADH are in line with those by Finocchiaro et al. [S] .
The reductive half-reaction. The rate of turnover of most acylCoA dehydrogenases is limited by the oxidative half-reaction, which, in turn, is governed by factors intluencing product dissociation [7, 9, MCADH is difficult using the best substrate (C,-CoA), even at 2°C because the rates are very fast (> 300 s -I , see also [7] ), although it is apparent that the two proteins behave in a similar fashion. We have thus selected C,,-CoA, which, from the data of Fig. 2 , is a good substrate for MCADH and the mutant. From the traces of the course of flavin reduction depicted in Fig. 4 , it can be concluded that the rates for MCADH and [Glu304]M-CADH are very similar with the substrate C,,-CoA. The reaction is biphasic in both cases with a fast (55 SKI) and a second, slower phase (14 s -~) , which are followed by a much slower phase involving equilibration [9] .
Thermal effects, time dependence of inactivation and Arrhenius energy of activation. The effect of temperature on the activity of purified human wild-type and the [Glu304]MCADH was determined upon incubation of samples for 15 min at the temperatures shown in Fig. 5. [Glu304]MCADH has about a 4°C lower temperature of 50% inactivation. This is in good agreement with the results obtained previously in extracts from E. cnli cells expressing these proteins 1301. MCADH displays 120 I " " I " " I " " i " " I " " l " " / " " / " " l an unusual region of increased stability at 42-45°C where the activity returns to the level observed at lower temperatures. This is most probably not due to an artefact because we reproduced the effect in multiple measurements of different preparations. at > 50°C the activity rapidly decreases, probably coinciding with the onset of thermal dissociation and irreversible inactivation. From the coincidence of these parameters, it is likely that the same basic mechanism(s) of thermal inactivation are operative for MCADH and [Glu304]MCADH.
The stability of MCADH and [Glu304]MCADH was investigated by measuring the decrease of activity at increasing time, and at different temperatures in E. coli crude extracts (Fig. 6A ) and in purified enzyme samples (Fig. 6B) . Both enzymes are stable on ice for more than 50 h. At 28 "C and at 37 "C the inactivation of the mutant enzyme in E. coli extracts (Fig. 6A) is =3-fold faster than observed with MCADH (for the half-times of inactivation see legend to Fig. 6 ). With purified enzyme samples the course of inactivation is biphasic (Fig. 6B ). The differences in the fast rate of inactivation between MCADH and [Glu304]-MCADH is =2-fold; it is much more pronounced (4-7-fold) in the slow phase.
DISCUSSION
The new expression system is a crucial improvement over the previous ones [6, 7] because it allows the expression in crude extracts of [Glu304]MCADH to about 20% the total activity content found with MCADH under comparable conditions. It also permits the isolation of apparently homogeneous [Glu304]-MCADH in two chromatographic steps in about 20% yield (Table 1). Our results contrast with previous reports that this mutant is unstable and cannot be purified [28, 521 . In our hands, the greatest loss of mutant MCADH occurs in the first ammonium sulfate cut (Table 1 ) and may be due to the presence of incorrectly folded or partially degraded active [Glu304]MCADH in the crude extract.
The physicochemical properties of highly purified MCADH, [Glu304]MCADH and of pig kidney MCADH are, overall, quite similar (Table 2 ). There are, however, some significant differences among them. First, the redox potential of the human enzyme is some 30 mV higher than that of pig kidney MCADH. This is reflected in the larger extent of bleaching of pig kidney MCADH with substrate ( Table 2 , Fig. 1 ). The differences in bleaching between MCADH and [Glu304]MCADH are probably due to differences in affinity for substrate/product. Second, and more importantly, some interesting aspects emerge upon inspection of the catalytic parameters of [Glu304]MCADH as compared to those of MCADH. It is likely that the differences in activity observed with substrates C, to C,, are due not to lower rates in the reductive half-reaction, which are essentially identical (Fig. 4) , but to the mode of interaction with the electron acceptor. Third, the most astonishing difference is the shift in substrate specificity (Fig. 2) with the [Glu304]MCADH, which might more appropriately be named a long-chain acyl-CoA dehydrogenase because it exhibits highest efficiency with C,JC,,-CoA substrates rather than with C,-CoA, as with normal human MCADH. Recent insights [32] , suggest that the volume of the substrate binding pocket is important in determining substrate chain-length specificity. We therefore infer that the active site of [Glu304]MCADH may be more flexible and tolerant with respect to substrate chain length, i.e. size. In fact, the mutant MCADH is more active than MCADH with C,-CoA, and is active, albeit at low levels, with C,,-CoA, whereas MCADH is not (Table 3) . Fourth, the data shown in Figs 5 and 6 document an important decrease in stability both with time and temperature for [Glu304]MCADH. This confirms previous results obtained with crude cell extracts [30] . The biphasic inactivation behavior of the purified enzymes (Fig. 6B) is compatible with a transition into a less active form, which might be much more susceptible to proteolytic degradation in crude extracts (Fig. 6A) and, more relevantly so, in vivo. This instability possibly originates from the modified interactions of the H and I helices around positions 304 in the center of the MCADH tetramer and may be secondary to the higher flexibility of the substrate binding pocket.
The significantly decreased activity of [Glu304]MCADH compared to MCADH observed with the natural electron acceptor, ETF, and the higher K , values for medium-chain substrates may well contribute to the disease mechanism in patients homozygous for this mutation. It would be of interest to know whether these effects also occur in hetero-tetrameric MCADH, consisting of two different types of monomers, which would be expected to occur in individuals heterozygous for the K304E mutation. Our groups [26] and others [28, 291 have shown earlier that the K304E mutation has a major impact on folding and assembly of the polypeptide. Higher levels of chaperonins increase the yield of active [Glu304]MCADH in bacteria in agreement with impaired formation of tertiary and quarternary structures [30] . The difference in [Glu304]MACDH activity produced at 28 "C and 37 "C is in line with the notion that folding and assembly are a major factor in the generation of disease. In addition to that, the modified chain-length spectrum and K,/ V,,, of [Glu304]MCADH could adversely affect the substrate specificity pattern of the P-oxidation process. Decreased levels of MCADH due to impaired folding and tetramer assembly may thus be further potentiated by a hole in the substrate affinity for C,-acyl-CoAs. The persistent occurrence of elevated levels of glycine conjugates with medium-length acyl chains observed also in asymptomatic periods [53] may thus be due to a combination of this hole in the substrate affinity and the decreased level of [Glu304]MCADH resulting from impaired folding, assembly and stability of the mutant variant. The contribution of each of these multiple effects of the K304E mutation observed experimentally to the phenotypes expressed in the patient organism remains to be established. This work was supported by grants from the Deutsche Forschungsgemeinschaft (Gh 214-7, Gh 2/6-1) to SG and from the National Institutes of Health (AM20407) to AWS.
